Peginesatide acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for peginesatide acetate and what is the scope of freedom to operate?
Peginesatide acetate
is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.Peginesatide acetate has one hundred and fourteen patent family members in thirty-four countries.
Summary for peginesatide acetate
| International Patents: | 114 |
| US Patents: | 6 |
| Tradenames: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | peginesatide acetate at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for peginesatide acetate
US Patents and Regulatory Information for peginesatide acetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-002 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-008 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-007 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-005 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-006 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-005 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-001 | Mar 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for peginesatide acetate
International Patents for peginesatide acetate
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| China | 1823088 | Novel peptides that bind to the erythropoietin receptor | ⤷ Sign Up |
| Croatia | P20090251 | ⤷ Sign Up | |
| Spain | 2395413 | ⤷ Sign Up | |
| Brazil | PI0613233 | composto para tratar um paciente tendo um distúrbio | ⤷ Sign Up |
| Eurasian Patent Organization | 010099 | ПЕПТИДЫ, КОТОРЫЕ СВЯЗЫВАЮТСЯ С РЕЦЕПТОРОМ К ЭРИТРОПОЭТИНУ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ (NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AND METHODS FOR USE THEREOF) | ⤷ Sign Up |
| European Patent Office | 2204193 | Groupe espaceur pour composés à base de peptides de poly(éthylèneglycol) modifiés (Novel spacer moiety for poly(ethylene glycol)-modified peptide-based compounds) | ⤷ Sign Up |
| Eurasian Patent Organization | 200501800 | НОВЫЙ РАЗДЕЛИТЕЛЬНЫЙ ФРАГМЕНТ (СПЕЙСЕР) ДЛЯ МОДИФИЦИРОВАННЫХ ПОЛИЭТИЛЕНГЛИКОЛЕМ СОЕДИНЕНИЙ НА ОСНОВЕ ПЕПТИДОВ | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
